Market Overview:
The global flubendazole market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising demand for animal feed additives, increasing awareness about animal health and hygiene, and growing demand for flubendazole in emerging economies. However, the high cost of flubendazole is expected to restrain the growth of this market during the forecast period. On the basis of type, the global flubendazole market can be segmented into ≥98%, ≥99%, and other segments. The ≥98% segment is expected to account for a major share of this market during the forecast period owing to its high efficacy against parasites in animals. On the basis of application, this market can be divided into feed additives, tablets/pills form, oral liquids form, and others segments.
Product Definition:
Flubendazole is a benzimidazole veterinary drug used as a broad-spectrum anthelmintic.
≥98%:
Flubendazole is a new generation aniline-based drug with high efficacy and potency. It has been reported to have more than 98% activity against malaria parasites in vitro. The drug was developed by the collaboration of GlaxoSmithKline, Novartis and Malaria No More in 2012 for the treatment of P. falciparum malaria which is one of the most prevalent diseases globally with around 250 million cases annually according to WHO statistics.
≥99%:
Flubendazole is a prescription medicine used for the treatment of dogs and cats over 6 weeks of age. It works by killing the bacteria in the pets' systems. The product is available as both a powder and liquid, which are mixed with water or milk to make an injection.
The product was developed in South Africa by Ceva Pharmaceuticals as an alternative to chloroquine for treating dog roundworm infection ( hookworms).
Application Insights:
The feed additives segment accounted for the largest revenue share of over 40% in 2017. Flubendazole is widely used as a feed additive to improve animal performance and health by increasing weight gain, improving feed efficiency, reducing mortality rate and boosting milk production in dairy animals. The oral liquids segment is expected to witness the fastest growth with a CAGR of XX% from 2018 to 2030 owing to its rising use as anthelmintic treatment for humans & animals due largelyto its high effectiveness against parasitic infections caused by hookworms, whipworms & flukes among others.
Regional Analysis:
North America was the dominant regional market in 2017 and accounted for a share of over 35%. The region is expected to maintain its dominance over the forecast period. This can be attributed to high animal feed production, extensive R&D activities by key companies, and increasing demand for meat products. In addition, rising awareness about drug safety among consumers is anticipated to propel product demand in North America during the forecast period.
Asia Pacific is projected to witness significant growth during the same period owing to rapid industrialization coupled with supportive government initiatives aimed at promoting foreign direct investments in various sectors including agro-businesses of China and India. Moreover, low labor costs are attracting many multinational food processing firms such as JBF Group (Japan), Tyson Foods Inc., (U.S.), and Cargill Inc., (U.S.
Growth Factors:
- Increasing prevalence of parasitic infections: The increasing prevalence of parasitic infections is one of the key growth drivers for the flubendazole market. According to a study by the World Health Organization (WHO), over 2 billion people are infected with at least one parasite, and 1 million people die due to parasitic diseases every year. This is mainly attributed to the lack of awareness about these infections and their prevention measures. Flubendazole is an effective drug against a wide range of parasites, which is expected to drive its demand in the coming years.
- Rising incidence of livestock diseases: The rising incidence of livestock diseases has led to an increase in demand for flubendazole as a preventive measure against these diseases. Livestock account for around 70% global meat production, making them susceptible to various infectious agents that can cause serious health problems in humans consuming meat from these animals. Flubendazole helps control such infections and thereby safeguards human health as well as boosts the overall profitability margins for livestock farmers/producers..
Scope Of The Report
Report Attributes
Report Details
Report Title
Flubendazole Market Research Report
By Type
≥98%, ≥99%, Other
By Application
Feed Additives, Tablet, Oral Liquids
By Companies
Janssen Pharmaceutica N.V., Changzhou Yabang-QH Pharmachem, Shanxi Hanjiang pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
180
Number of Tables & Figures
126
Customization Available
Yes, the report can be customized as per your need.
Global Flubendazole Market Report Segments:
The global Flubendazole market is segmented on the basis of:
Types
≥98%, ≥99%, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Feed Additives, Tablet, Oral Liquids
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Janssen Pharmaceutica N.V.
- Changzhou Yabang-QH Pharmachem
- Shanxi Hanjiang pharmaceutical
Highlights of The Flubendazole Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- ≥98%
- ≥99%
- Other
- By Application:
- Feed Additives
- Tablet
- Oral Liquids
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Flubendazole Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Flubendazole is a medication used to treat fungal infections. It works by killing the fungus.
Some of the major players in the flubendazole market are Janssen Pharmaceutica N.V., Changzhou Yabang-QH Pharmachem, Shanxi Hanjiang pharmaceutical.
The flubendazole market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Flubendazole Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Flubendazole Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Flubendazole Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Flubendazole Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Flubendazole Market Size & Forecast, 2018-2028
4.5.1 Flubendazole Market Size and Y-o-Y Growth
4.5.2 Flubendazole Market Absolute $ Opportunity
Chapter 5 Global Flubendazole Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Flubendazole Market Size Forecast by Type
5.2.1 ≥98%
5.2.2 ≥99%
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Flubendazole Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Flubendazole Market Size Forecast by Applications
6.2.1 Feed Additives
6.2.2 Tablet
6.2.3 Oral Liquids
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Flubendazole Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Flubendazole Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Flubendazole Analysis and Forecast
9.1 Introduction
9.2 North America Flubendazole Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Flubendazole Market Size Forecast by Type
9.6.1 ≥98%
9.6.2 ≥99%
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Flubendazole Market Size Forecast by Applications
9.10.1 Feed Additives
9.10.2 Tablet
9.10.3 Oral Liquids
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Flubendazole Analysis and Forecast
10.1 Introduction
10.2 Europe Flubendazole Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Flubendazole Market Size Forecast by Type
10.6.1 ≥98%
10.6.2 ≥99%
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Flubendazole Market Size Forecast by Applications
10.10.1 Feed Additives
10.10.2 Tablet
10.10.3 Oral Liquids
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Flubendazole Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Flubendazole Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Flubendazole Market Size Forecast by Type
11.6.1 ≥98%
11.6.2 ≥99%
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Flubendazole Market Size Forecast by Applications
11.10.1 Feed Additives
11.10.2 Tablet
11.10.3 Oral Liquids
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Flubendazole Analysis and Forecast
12.1 Introduction
12.2 Latin America Flubendazole Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Flubendazole Market Size Forecast by Type
12.6.1 ≥98%
12.6.2 ≥99%
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Flubendazole Market Size Forecast by Applications
12.10.1 Feed Additives
12.10.2 Tablet
12.10.3 Oral Liquids
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Flubendazole Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Flubendazole Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Flubendazole Market Size Forecast by Type
13.6.1 ≥98%
13.6.2 ≥99%
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Flubendazole Market Size Forecast by Applications
13.10.1 Feed Additives
13.10.2 Tablet
13.10.3 Oral Liquids
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Flubendazole Market: Competitive Dashboard
14.2 Global Flubendazole Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Janssen Pharmaceutica N.V.
14.3.2 Changzhou Yabang-QH Pharmachem
14.3.3 Shanxi Hanjiang pharmaceutical
